GENETIC STUDY OF HYPERLEPOPROTEINAEMIA TYPES IV AND V.FRANCOIS J; LENTINI F; HOSTE P et al.1977; CLIN. GENET.; DENM.; DA. 1977; VOL. 12; NO 4; PP. 202-207; BIBL. 20 REF.Article

GLUCOSE ASSIMILATION AND INSULIN SECRETION IN I.V. GTT IN NORMAL DOGS INFLUENCE OF ATROPINE AND PENTOBARBITALMATTHEEUWS D; ROTTIERS R; KANEKO JJ et al.1980; HORM. METAB. RES.; ISSN 0018-5043; DEU; DA. 1980; VOL. 12; NO 10; PP. 553-554; BIBL. 8 REF.Article

HYPERINSULINISM IN THE DOG DUE TO PANCREATIC ISLET-CELL TUMOUR: A REPORT ON THREE CASESMATTHEEUWS D; ROTTIERS R; DE RIJCKE J et al.1976; J. SMALL ANIMAL PRACT.; G.B.; DA. 1976; VOL. 17; NO 5; PP. 313-318; BIBL. 16 REF.Article

Androgen plasma levels in male diabeticsANDO, S; RUBENS, R; ROTTIERS, R et al.Journal of endocrinological investigation (Testo stampato). 1984, Vol 7, Num 1, pp 21-24, issn 0391-4097Article

Self blood glucose monitoring: evaluation of haemo-glukotest 20-800R, Visidex I and RefloluxVAN CROMBRUGGE, P; ROTTIERS, R; VERMEULEN, A et al.Diabète et métabolisme (Paris). 1985, Vol 11, Num 4, pp 210-215, issn 0338-1684Article

EFFECTS OF LONG-TERM TREATMENT WITH SULOCTIDIL ON BLOOD VISCOSITY, ERYTHROCYTE DEFORMABILITY AND TOTAL FIBRINOGEN PLASMA LEVELS IN DIABETIC PATIENTSRONCUCCI R; DE HERTOGH R; DORMANDY JA et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 4; PP. 682-684; ABS. GER; BIBL. 30 REF.Article

Circulating plasma vascular endothelial growth factor and microvascular complications of Type 1 diabetes mellitus : the influence of ACE inhibitionCHATURVEDI, N; FULLER, J. H; POKRAS, F et al.Diabetic medicine. 2001, Vol 18, Num 4, pp 288-294, issn 0742-3071Article

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lisproHOLLEMAN, F; SCHMITT, H; ROTTIERS, R et al.Diabetes care. 1997, Vol 20, Num 12, pp 1827-1832, issn 0149-5992Article

IA-2 autoantibodies predict impending Type I diabetes in siblings of patientsDECOCHEZ, K; DE LEEUW, I. H; PIPELEERS, D. G et al.Diabetologia (Berlin). 2002, Vol 45, Num 12, pp 1658-1666, issn 0012-186X, 9 p.Article

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onsetDECOCHEZ, K; KEYMEULEN, B; KAUFMAN, L et al.Diabetes care. 2000, Vol 23, Num 8, pp 1072-1078, issn 0149-5992Article

Different risk factors of microangiopathy in patients with Type I diabetes mellitus of short versus long duration. The EURODIAB IDDM complications studyKARAMANOS, B; PORTA, M; SONGINI, M et al.Diabetologia (Berlin). 2000, Vol 43, Num 3, pp 348-355, issn 0012-186XArticle

Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted : possible relation to increased body mass indexWEETS, I; VAN AUTREVE, J; DORCHY, H et al.Diabetologia (Berlin). 2001, Vol 44, Num 1, pp 40-47, issn 0012-186XArticle

ARE ACE-INHIBITORS OR ARB'S STILL NEEDED FOR CARDIOVASCULAR PREVENTION IN HIGH RISK PATIENTS? INSIGHTS FROM PROFESS AND TRANSCENDVAN MIEGHEM, W; BILLIOUW, J.-M; ROTTIERS, R et al.Acta clinica belgica (Ed. multilingue). 2010, Vol 65, Num 2, pp 107-114, issn 0001-5512, 8 p.Article